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Introduction

Dlk1 is an imprinted transmembrane signaling molecule
Delta-like 1 (DLK1), also known as preadipocyte factor 1 (PREF-1), is a single-pass transmembrane protein containing EGF-like repeats homologous to the Notch ligands Delta, Jagged and Serrate (Smas and Sul, 1993) . Unlike these ligands, however, DLK1 lacks a Notch interaction domain and may act as a repressor of Notch signaling (Ross et al., 2004) . Fulllength DLK1 is cleaved in the juxtamembrane region by tumor necrosis factor a converting enzyme (TACE; ADAM17) to generate a soluble form of the protein that is referred to as fetal antigen 1 (FA1) (Bachmann et al., 1996; Smas et al., 1997; Wang and Sul, 2006) . DLK1 has been implicated in multiple developmental processes including the differentiation of neuroendocrine cells and hepatocytes, hematopoiesis, osteogenesis and adipogenesis (Bauer et al., 1998; Floridon et al., 2000; Kaneta et al., 2000; Moore et al., 1997; Ohno et al., 2001; Tanimizu et al., 2003) (Abdallah et al., 2004; Garces et al., 1999; Lee et al., 2003; Li et al., 2005; Sakajiri et al., 2005; 0925-4773/$ -see front matter Ó 2012 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mod.2012.09.010 1993). Overall, DLK1 appears to function in numerous cell types to regulate the switch from immature proliferating cells to a mature differentiated state.
Dlk1 is subject to genomic imprinting with expression only from the paternally inherited allele, while the maternally inherited allele remains silent (Kobayashi et al., 2000; Schmidt et al., 2000; Takada et al., 2000) . In the mouse, Dlk1 expression is first observed at embryonic day 11 (e11), with levels increasing until late gestation (Schmidt et al., 2000; Smas and Sul, 1993) . At e12.5, Dlk1 expression is high in the developing pituitary gland, pancreas, lung, adrenal gland, placenta, and many mesodermally-derived tissues, such as skeletal muscle and cartilage (da Rocha et al., 2007; Smas and Sul, 1993; Yevtodiyenko and Schmidt, 2006) . In human embryos, DLK1 expression mirrors that seen in the mouse, with adult expression restricted to specific cell types, including b-cells of the pancreas, somatotrophs of the pituitary gland, bone marrow, adrenal gland, and skeletal muscle (Floridon et al., 2000; Jensen et al., 1994 Jensen et al., , 1993 Larsen et al., 1996; Schmidt et al., 2000; Tornehave et al., 1996) .
Dlk1 functions to maintain undifferentiated cell populations
Studies performed in a variety of cell culture systems suggest that the primary role for DLK1 is to maintain the multipotency of progenitor cells until it is appropriate for them to differentiate. DLK1 function has been studied most extensively during the process of adipogenesis, the differentiation of preadipocyte cells to mature adipocytes. In preadipocyte cells, high levels of DLK1 coincide with ongoing proliferation and maintenance of the preadipocyte state. Dlk1 is downregulated as adipogenesis begins, and forced expression of Dlk1 at this time blocks preadipocyte differentiation (Smas and Sul, 1993) . The specific functional roles of the membranebound and soluble forms of DLK1 remain unclear, however, and existing data is often contradictory (Boney et al., 1996; Garces et al., 1999; Mei et al., 2002; Nueda et al., 2007; Zhang et al., 2003) . One extant hypothesis is that the membranebound and secreted forms of the protein play opposing roles in adipogenesis, and that the ratio of membrane-to-secreted protein determines whether cells proceed with differentiation (Garces et al., 1999 ).
Dlk1 associates with growth regulatory factors
The b-cells of the pancreas and the somatotrophs of the pituitary are neuroendocrine cells, producing circulating hormones under the control of signals from the nervous system. The b-cells produce Insulin in response to serum glucose levels, while the somatotrophs secrete Growth hormone (GH), the major endocrine regulator of postnatal growth. The interactions between DLK1, GH and Insulin are many and complex, with specific roles poorly defined. Abdallah et al. reported an inverse correlation between serum DLK1 and GH, as mice with increased levels of circulating GH showed reduced amounts of the soluble DLK1 product FA1 (Abdallah et al., 2007) . In rat preadipocytes, however, exogenous GH prevented the differentiation-induced downregulation of Dlk1 expression and inhibited the differentiation process (Hansen et al., 1998) . GH exerts many of its effects by stimulating production of Insulin-like growth factor I (IGF-I), and overexpression of DLK1 reduces IGF-I signaling, which reflects the ability of DLK1 to downregulate GH (Lupu et al., 2001; Zhang et al., 2003) . Another layer of regulation may be present in the individual roles of the transmembrane and soluble forms of DLK1, which have been little explored in these systems.
The placenta is also an endocrine tissue, and plays a major role in controlling fetal growth by the production of growth factors and through regulation of nutrient transfer to the fetus. Significant placental dysfunction invariably leads to fetal death, while milder defects result in growth retardation that can persist long after birth (Charalambous et al., 2007) . We have shown previously that Dlk1 is expressed in the fetal endothelial cells of the mid-gestation placental labyrinth, the site of maternal-fetal exchange . The function of Dlk1 in the placental labyrinth is unknown, but is intriguing given the importance of the placenta in fetal growth and survival.
1.4.
Mouse models define a role for Dlk1 in growth regulation Several mouse models have been generated that display altered Dlk1 expression, either in isolation or in combination with other linked imprinted genes, and these invariably show changes in growth. Previously described Dlk1 null mice (Dlk1 tm1Hsul , referred to here as Dlk1
Sul-pat to indicate paternal inheritance of the mutant allele) exhibit significant neonatal lethality, and animals surviving the neonatal period show growth retardation, skeletal defects and reduced adipose tissue as adults (Moon et al., 2002) . Dlk1 Sul-pat survivors are 14%
smaller than wild type (WT) littermates at weaning, but attain a normal weight by 10-15 weeks of age (Moon et al., 2002) . Two additional mouse models, Gtl2lacZ and Gtl2D5'Neo, have bacterially derived transgene sequences inserted in the Maternally-expressed gene 3 (Meg3) imprinting control region located downstream of Dlk1 (Schuster-Gossler et al., 1996; Sekita et al., 2006; Steshina et al., 2006) . These models show partial early lethality and decreased growth, and reduced Dlk1 levels have been demonstrated in both lines. Mice with a twofold increase in Dlk1 levels display developmental overgrowth and early postnatal lethality, while those expressing a threefold Dlk1 increase show embryonic lethality with edema and lung and skeletal defects (da Rocha et al., 2009) . When constitutive gene deletions produce complex phenotypes, identifying the tissues or cell types responsible for individual aspects of that phenotype can be difficult. This is particularly true when investigating systemic parameters such as survival and growth, which are regulated by processes originating within multiple systems. Conditional or ''floxed'' alleles allow the sequential examination of gene function in candidate cell types against a WT background. We generated a conditional allele for the Dlk1 gene (Dlk1 , referred to here as Dlk1 flox ), to investigate the global aspects of the Dlk1 null phenotype, focusing on the early lethality and growth effects. We identified three neuroendocrine sites of Dlk1 expression as potentially causative for these phenotypes, the b-cells of the pancreas, the somatotrophs of the pituitary and endothelial cells, particularly the fetal endothelial cells of the placental labyrinth. As the process of producing mice with a conditional Dlk1 allele also generates animals with a constitutive deletion (Dlk1 cons-pat ), these mice were characterized and compared to the existing Dlk1
Sul-pat animals, confirming and extending the Dlk1 null phenotype.
Results
2.1.
Generation of Dlk1 flox and Dlk1 cons mice
A conditional Dlk1 gene targeting vector was designed to flank exons 5 and 6 with loxP sites, to produce an allele that would allow both constitutive and conditional Dlk1 deletions (Fig. 1) . Exons 5 and 6 account for 77% of the DLK1 protein coding sequence, including four of six EGF-like domains and the transmembrane domain, and therefore this allele is expected to be a null. This is a significantly larger deletion than that present in the Dlk1 Sul-pat mice, which have portions of exons 3 and 4 removed. The Dlk1 targeting construct was transfected into E14 embryonic stem (ES) cells and clones were selected using the neomycin analog G418. Surviving clones were screened by Southern blotting, and two correctly targeted clones were microinjected into C57BL/6 (B6) blastocysts. One clone yielded high percentage chimeras which were crossed to B6 females to achieve germline transmission. The resulting mice were designated Dlk1 3lox
, and carried Dlk1 exons 5 and 6 flanked by loxP sites, with a loxP-flanked Neo cassette (Fig. 1) . Dlk1 3lox mice were bred to EIIa-Cre animals, which express
Cre recombinase from the one cell stage. The offspring from this cross carried one of three different recombination patterns upon genotyping, found in roughly equivalent proportions. Recombination between the loxP1 and loxP3 sites excised Dlk1 exons 5 and 6 and the neomycin cassette, generating a Dlk1 constitutive knockout mouse line (Dlk1 cons ) ( Fig. 1) . Recombination between the loxP2 and loxP3 sites generated mice in which Neo was removed and exons 5-6 were flanked by loxP sites to allow subsequent conditional deletion (Dlk1 flox ). Recombination between the loxP1 and loxP2 sites generated animals with an exon 5-6 deletion and Neo remaining in the locus; these mice were not experimentally useful and were not examined further.
Conditional alleles must retain normal activity after loxP insertion for them to be useful in tissue specific studies. To confirm that introducing loxP sites into the Dlk1 flox mice did not affect normal Dlk1 expression, mRNA levels were examined by Northern blotting of embryos and placentae at e12.5 using a probe specific for Dlk1 exon 6. Since Dlk1 is expressed only from the paternally inherited allele, unless specified all analysis presented here was performed on paternal heterozygotes, animals in which the floxed allele was inherited paternally (Dlk1
flox-pat
). Animals from the reciprocal cross, in which the floxed allele was inherited maternally (Dlk1 flox-mat ), in addition to WT littermates from each cross, were used as controls. Dlk1 levels in Dlk1 flox-pat mice were not significantly different from WT, suggesting no effect of the loxP insertion ( Fig. 2A and B ). Northern analysis with the same exon 6 probe was also used to verify loss of Dlk1 expression in animals inheriting the constitutive allele paternally (Dlk1 cons-pat ), and Dlk1 levels were found to be 7.3% and 3.7% of WT in embryos and placentae, respectively ( Fig. 2C and D) . This residual Dlk1 signal represents basal expression from the imprinted maternal allele, a phenomenon observed at many imprinted loci (DeChiara et al., 1990 (DeChiara et al., , 1991 Schmidt et al., 1999; Zhang et al., 1993) . This fact was confirmed by the complete loss of Dlk1 mRNA in e12.5 homozygous Dlk1 cons-mat/pat embryos and lethality was reported to have occurred within the first two days after birth, but data was not given for this parameter so direct comparisons cannot be made (Moon et al., 2002 (Fig. 3A) . Female and male mice were analyzed separately for growth throughout these studies, as sexspecific differences begin to emerge before weaning. At postnatal day 7 (P7), Dlk1 cons-pat female and male pups weighed 81% and 84% of WT, respectively, and this proportion increased to 89% and 87% by P42 (Fig. 3A) . Surviving Dlk1
Sul-pat animals also displayed growth retardation, weighing 85% of WT at weaning (Moon et al., 2002) . To examine whether the Dlk1 null growth phenotype begins during embryonic development, Dlk1 cons-pat embryos were weighed at e12.5, e14.5 and e16.5, but showed no significant differences from WT (Fig. 3B) Error bars denote SEM, n = 6 for each genotype, * denotes p < 0.01.
fat pads, reproductive fat pads, and testis were examined (n = 3 for each Dlk1 cons and WT). With the exception of placentae and fat pads (discussed below and in Section 2.4, respectively), no significant histological differences were detected in any tissues (data not shown). Dlk1 is strongly expressed in the fetal vasculature of the labyrinthine layer of the mouse placenta . Placental defects in mice can cause fetal death or reduced size at birth, similar to that seen in Dlk1 null mice, and defects in the analogous villous layer of the human placenta lead to developmental defects and fetal death (Anson-Cartwright et al., 2000; Kingdom et al., 2000) . Placental weight was analyzed in Dlk1 cons-pat animals at e12.5, e14.5, and e16.5, but no significant differences were observed from WT ( Fig. 3B ). Placental morphology was examined by histology of e12.5 Dlk1 cons-pat placentae in comparison to their WT littermates ( Fig. 4A-D) . Dlk1 cons-pat placentae had a labyrinth layer that was reduced in size, comprising an average of 62% of the total placental area, compared to 72% for WT animals (p = 0.04)( 
Dlk1 deficient mice demonstrate altered adipose tissue
Dlk1 Sul-pat mice had normal fat pad weights at 8 weeks of age, but at 16 weeks on a high fat diet, these mice showed a significant increase in fat pad weight (Moon et al., 2002 placentae from e12.5 to e16.5. n P 8 for each data point.
had resolved, and WT and Dlk1 cons-pat adipocytes were equal in size (1340 and 1328 lm 2 , respectively) ( Fig. 5C ).
Dlk1 deletion in pancreatic b-cells does not affect neonatal survival or growth
Mice lacking any one of several genes in the Insulin pathway show reduced birth weight, with perinatal lethality from ketoacidosis occurring approximately 48 h after birth (Accili et al., 1996; Duvillie et al., 1997; Joshi et al., 1996) . The timing of this lethality is similar to that seen in Dlk1
Sul-pat and Dlk1 cons-pat animals, and suggested that alterations in Insulin signaling during the critical newborn period might underlie the Dlk1 null lethality. Dlk1 is highly expressed in the b-cells of the pancreatic islets, and has multiple roles in regulating the Insulin/IGF-1 signaling pathway (Garces et al., 1999; Nueda et al., 2008) .
To assay the role of Dlk1 in pancreatic b-cells, a b-cellspecific Dlk1 deletion (called Dlk1 Ins ) was generated by crossing Dlk1 flox mice to the transgenic line rIP-Cre, which expresses Cre recombinase from the rat Insulin II promoter (Postic et al., 1999) . rIP-Cre mice have been reported to show some degree of glucose intolerance on their own, and the use of rIP-Cre controls is recommended to minimize any impact of this potentially confounding factor (Lee et al., 2006 (Fig. 6A) . This difference is not observed in females or in either sex at other time points, and was not explored further. The reciprocal cross generated 80/147 (54%) rIP-Cre animals and 67/147 (46%) Dlk1 Ins-mat animals; there was no difference in weight between these two groups, indicating no effect of a maternal Dlk1 b-cell deletion (Fig. 6A) . Under histological analysis, Dlk1 Ins-pat mice showed no changes in the size, number or morphology of adult islets, and all other tissues examined were normal ( Fig. 6B and C and data not shown).
To confirm that Cre-mediated excision in rIP-Cre mice was specific to the b-cells of the pancreas, and to verify the extent of Cre excision directed by this transgene, rIP-Cre mice were crossed to the B6.129S4-Gt(ROSA)26Sor tm1Sor /J reporter mouse line (referred to as ROSA26). In these mice, Cre recombinase excises a floxed stop codon to allow lacZ expression in cells where Cre is active (Soriano, 1999) . Pancreases from offspring of the rIP-Cre/ROSA26 cross were collected and analyzed for b-galactosidase activity at 6 weeks of age. In previous reports, rIP-Cre mice have been reported to excise a floxed gene in 82% of b-cells. Counting b-galactosidase positive cells in histological sections of rIP-Cre/ROSA26 pancreases showed 72% (413/ 572) of islet cells expressed lacZ, a number consistent with the estimate that 70-85% of islets are b-cells ( Fig. 6D and E) (Gannon et al., 2000) .
WT
Dlk1 Immunohistochemistry with an antibody against DLK1 was then used to verify the loss of DLK1 from islet cells in Dlk1
Ins-pat pancreases compared to rIP-Cre/+ controls ( Fig. 6F-I ). DLK1 levels in control islet cells were low but detectable, as expected in adult animals. Interestingly, high levels of DLK1 were seen in the acinar cells surrounding the islets, a tissue not previously shown to express DLK1 ( Fig. 6F and H) . Dlk1
Ins-pat mice show a virtually complete loss of DLK1 in the islets, confirming the efficiency of the rIP-Cre-mediated excision, and a significant decrease in acinar cell DLK1 ( Fig. 6G and I ). Loss of much of the DLK1 signal in the acinar cells indicates that the DLK1 present in WT pancreatic acini may originate from the b-cells, produced as a soluble protein form that is secreted to adjacent cells.
Dlk1 deletion in pituitary somatotrophs does not affect neonatal survival or growth
Mice deficient in the Growth hormone (Gh), Growth hormone receptor (Ghr), or Growth hormone receptor/binding protein genes (Ghr/bp) display a proportional dwarfism similar to that observed in Dlk1 null mice (Amselem et al., 1989; Wajnrajch et al., 1996; Zhou et al., 1997) . Dlk1 is expressed in the developing pituitary gland at e12.5, becoming restricted to the GH-producing somatotrophs of the mature pituitary (Larsen et al., 1996; Yevtodiyenko and Schmidt, 2006) . DLK1 is involved in GH regulation, but data on the specific relationship between DLK1 and GH are often contradictory, likely due to observations being made in different tissues or at differing points in development (Abdallah et al., 2007; Ansell et al., 2007; Carlsson et al., 1997; Hansen et al., 1998; Wolfrum et al., 2003) . Given these data, we hypothesized that the growth retardation of Dlk1 cons-pat and Dlk1 Sul-pat mice could be due to reduced GH signaling.
To assay the role of DLK1 in GH-producing somatotrophs, a somatotroph-specific Dlk1 deletion (called Dlk1 Gh ) was generated by crossing Dlk1 flox mice to the transgenic line rGh-Cre, which expresses Cre recombinase from the rat Growth hormone promoter (Luque et al., 2007) . To control for any effect of the Cre transgene, Dlk1 Gh mice were compared to littermates that were WT for Dlk1 but heterozygous for the rGh-Cre transgene (Lee et al., 2006 Quantification of adipocyte cell area determined using ImageJ software. Two independent images from three animals of each genotype were examined, therefore n = 6 for each genotype. For the six week data, 3,559 and 5,191 cells were measured from WT and Dlk1 cons-pat fat pads, respectively. For the sixteen week data, 1,871 and 1,329 cells were measured from WT and Dlk1 cons-pat fat pads, respectively. Error bars represent SEM. * denotes p = 2.5E-31.
though at six weeks female Dlk1 Gh-pat mice were found to be significantly smaller than rGh-Cre control females (Fig. 7A) . This difference was not observed in males, or in either sex at other time points, and was not considered further. The reciprocal cross generated 40/78 (51%) rGh-Cre control offspring and 38/78 (49%) Dlk1 Gh-mat offspring at weaning, and there was no difference in weight between these two groups, indicating no effect of a maternal Dlk1 somatotroph deletion ( Fig. 7A and data not shown) . Under histological analysis, Dlk1 Gh-pat mice showed no changes in the size or morphology of the adult pituitary, and with one exception all other tissues examined were normal ( Fig. 7B and C, data not shown). In 6 week old male Dlk1 Gh-pat mice, retroperitoneal/inguinal fat pads weighed significantly more than rGh-Cre control fat pads (data not shown). This difference was not observed in female Dlk1 Gh-pat mice, and is likely an artifact of the relatively small sample size. To confirm that Cre-mediated excision in rGh-Cre mice was specific to pituitary somatotrophs, and to verify the extent of Cre excision directed by this transgene, rGh-Cre mice were crossed to the ROSA26 reporter line. Pituitaries from offspring of the rGh-Cre/ROSA26 cross were collected and analyzed for b-galactosidase activity at 6 weeks of age. b-Galactosidase activity was seen in the anterior lobe of the pituitary, but absent from the posterior pituitary in these mice ( Fig. 7D and E) . The weak b-galactosidase activity seen at the edges of the intermediate lobe is believed to be bleedover resulting from the very strong anterior pituitary expression. rGh-Cre mice have been reported to excise a floxed gene in 99% of GH-producing cells of the anterior pituitary gland, but not in other anterior pituitary cell types such as gonadotropes or corticotropes (Luque et al., 2007) . Counting b-galactosidase positive cells in histological sections of pituitaries showed 45.2% (358/792) of anterior pituitary cells expressing lacZ, consistent with the estimate that somatotrophs comprise 40-50% of the anterior cells (Gannon et al., 2000) . Immunohistochemistry with the DLK1 antibody was used to confirm DLK1 presence in rGh-Cre/+ control pituitaries ( Fig. 7F and H) , and its loss in Dlk1
Gh-pat pituitaries ( Fig. 7G and I) . Additionally, fluorescence activated cell sorting was used to isolate somatotrophs from Dlk1 Gh-pat and control littermate pituitaries using a GH antibody. DNA was extracted from both cell populations and a region spanning the exon 5/6 deletion was amplified by PCR using primers within loxP1 and downstream of Dlk1 exon 6 (Fig. 1) . Sequencing of the product amplified from Dlk1 Gh-pat cells confirmed the excision of Dlk1 exons 5 and 6 in this target tissue (data not shown). Images are shown in black and white for DLK1 alone (F and G) and in color with DLK1 (red) and DAPI (blue) merged (H and I). Scale bars in B-I equal 100 lm.
To determine if loss of Dlk1 expression in somatotrophs alters Gh levels, quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to analyze levels of Dlk1 and Gh mRNA in total adult mouse pituitary. In Dlk1
Gh-pat mice, Dlk1 expression was decreased to 28% of control levels (Fig. 7J) . The residual Dlk1 expression is likely due to low levels of Dlk1 expression from the intermediate and posterior lobes of the pituitary, and/or incomplete excision in a small population of somatotrophs (Larsen et al., 1996; Yevtodiyenko and Schmidt, 2006) . Growth hormone mRNA levels were unchanged in Dlk1
Gh-pat mice, which correlates with the lack of a growth defect in these animals, and indicates that Dlk1 is not required for Gh expression in somatotrophs (Fig. 7J) .
Dlk1 deletion in endothelial cells does not affect neonatal survival or growth
Dlk1 is expressed in endothelial cells in a variety of embryonic tissues and in the fetal-derived endothelium of the placental labyrinth (Bondjers et al., 2006; Jensen et al., 1994; Yevtodiyenko and Schmidt, 2006) . In adipose and skeletal muscle, two tissues that express high levels of Dlk1, the expressing cells have been shown to include the endothelial cells of the stroma (Andersen et al., 2009a,b; Waddell et al., 2010) . These data suggested a previously unexpected role for Dlk1 production in the vasculature of expressing tissues, where it might exert key functions by acting in a paracrine ) were generated by crossing Dlk1 flox mice to the transgenic lines Tie1 (Tunica intima endothelial kinase 1)-Cre and Tie2-Cre, which express Cre recombinase under the control of the mouse Tie1 and Tie2 promoters, respectively (Gustafsson et al., 2001; Koni et al., 2001) . We were interested specifically in the role of Dlk1 in placental endothelial cells, yet a promoter unique to this population of cells has not yet been described. The Tie1 and Tie2 genes are both expressed in placental endothelium, and in overlapping patterns of fetal endothelial cells, with Tie2 having a more widespread distribution (Gustafsson et al., 2001; Koni et al., 2001 ). Tie1-Cre mediated excision has exhibited 70-90% efficiency in adult kidney, liver and brain and 90-95% efficiency in lung and heart (Gustafsson et al., 2001) . Tie2-Cre has demonstrated 85-100% excision in bone marrow cells, 100% in lymph node vasculature, 84% of early hematopoietic progenitors, and 82% of blood cells in the embryonic yolk sac (Koni et al., 2001; Tang et al., 2010) . Conditional deletions were generated using both Cre transgenic lines due to concern that a broad Dlk1 deletion in fetal endothelium might obscure any placental effect, while a consistent phenotype from both deletions would suggest a placental cause. To control for any effect of the Cre transgenes, Dlk1 Tie1 and Dlk1
Tie2
mice were compared to control littermates that were WT for Dlk1 but heterozygous for the Tie1-Cre or Tie2-Cre transgenes (Lee et al., 2006 
Dlk1
Tie2 mice showed no differences in body weight in comparison to control animals up to 6 weeks of age, indicating no effect of a Dlk1 deletion in endothelial cells ( Fig. 8A and  B) . The loss of DLK1 from placental endothelial cells was confirmed by immunohistochemistry using a DLK1 antibody on Dlk1 Tie1-pat placentae in comparison to control placentae ( Fig. 8C-F) . This analysis showed significant reduction in DLK1 levels in Dlk1 Tie1-pat placenta, indicating efficient Tie1-Cre-mediated Dlk1 excision. As no survival or growth phenotype was seen in these animals the placental structure was not analyzed histologically.
Discussion
Mice lacking Dlk1 display a complex developmental phenotype, most intriguingly a partially penetrant neonatal lethality with proportional dwarfism of the survivors. Changes in systemic parameters such as survival and growth reflect the expression profile of Dlk1 in neuroendocrine tissues, which produce paracrine or endocrine circulating hormones. Systemic phenotypes are among the most difficult to study, however, and the identification of the specific causative tissue or cell type can require the production of complex animal models. The ability to generate tissue-specific deletions using floxed alleles in gene targeted mice has greatly simplified this process. In this work, we have used four separate conditional mouse deletions to explore the requirement for Dlk1 in three discrete cell types. We show, surprisingly, that none of these cell types, primary candidates for Dlk1 systemic functional roles, are responsible for the lethality or the growth defects of Dlk1 cons-pat mice. The cell type(s) that employ Dlk1 in the regulation of these key developmental parameters remain to be identified.
Dlk1 null mice display neonatal lethality and growth retardation
Dlk1
cons-pat mice carrying an exon 5-6 deletion largely recapitulate the lethality and dwarfism seen in the previously described Dlk1
Sul-pat mice, but show differences in the appearance of placental and adipose tissue. Significantly, we analyzed the placentae of Dlk1 cons mice, a tissue that was not studied in Dlk1 Sul-pat animals. Histological analysis of Dlk1 cons-pat placentae revealed subtle but consistent morphological changes in the placental labyrinth, including a smaller labyrinth with a reduced vascular compartment that may act to alter maternal nutrient provisioning to the developing fetus. Placental function is key to proper embryonic and postnatal development, and further examination of placental Dlk1 function is warranted. Dlk1 cons-pat mice had fat pads of normal weight, but showed a decrease in individual fat cell size when fed a standard diet. Despite having hypotrophic fat cells, Dlk1 cons-pat mice were still able to correct their early growth deficit to some extent, attaining 88% of WT weight at 6 weeks of age. Dlk1 Sul-pat mice displayed increased fat pad weight, hypertrophic adipocytes, and increased lipid metabolite levels in 16 week old animals fed a high fat diet (Moon et al., 2002) . Paradoxically, transgenic mice overexpressing Dlk1 and fed a high fat diet exhibit hypotrophic adipocytes similar to what is observed in Dlk1 cons-pat animals (Villena et al., 2008) . Differences in age and diet likely explain these differences, and support complex and changing roles for Dlk1 in adipogenesis.
Dlk1 is dispensable in multiple expressing tissues
Analysis of the Dlk1
, and Dlk1 Tie2 conditional knockout mice led us to conclude that the neonatal lethality and weight deficiency observed in the Dlk1 cons mice does not result from the loss of Dlk1 expression in b-cells of the pancreas, somatotrophs of the pituitary, or endothelial cells. The cell types targeted were those in which Dlk1 is known or believed to be involved in pathways that could underlie neonatal death and/or growth retardation. Our hypothesis was that the loss of Dlk1 in b-cells would result in neonatal lethality, while loss in somatotrophs would result in growth deficiency. Absence of Dlk1 from endothelial cells, particularly those in the placental labyrinth, could contribute to both lethality and growth defects. As none of the cell-specific deletions recapitulated these parameters as seen in Dlk1 cons-pat mice, and uncovered no additional phenotypes, we conclude that Dlk1 expression in these cell types is not required for normal growth and survival.
Roles for Dlk1 in development and growth
The surprising findings that the most obvious parameters of the Dlk1 null phenotype cannot be recapitulated by individual deletions in several predominant Dlk1-expressing tissues calls for a reevaluation of the biological roles attributed to Dlk1. There are several possible explanations for the origin of the Dlk1 cons-pat phenotype, and the inability of these conditional deletions to reproduce its effects. First, it is possible that much of the Dlk1 cons-pat phenotype derives solely or largely from expression in a key tissue not yet examined. One candidate is the adrenal gland, as Dlk1 is expressed both in the chromaffin cells of the adrenal medulla, and in the cortical zona glomerulosa . The adrenal gland functions to regulate physiological parameters such as electrolyte balance and stress responses. Acd (Adrenocortical dysplasia) mice display abnormal adrenal cortex morphology with reduced levels of glucocorticoids; these mice are 55-65% of normal weight at birth and 40% of mutants die within 24 h (Heikkila et al., 2002) . Wnt4 (Wingless-type MMTV integration site family, member 4) mutant mice show significantly reduced aldosterone levels without obvious histological change in the zona glomerulosa (Beamer et al., 1994) . Wnt4 mice die soon after birth, but the multiple defects they present makes it difficult to ascribe the cause to adrenal dysfunction. Dlk1 null mice show no overt adrenal changes by histology, but as the Wnt4 mice demonstrate, dysplasia is not strictly required for adrenal dysfunction. Recent work has shown that Dlk1 is expressed at high levels in undifferentiated brown adipose tissue (BAT), with expression peaking during late embryogenesis and then declining (Armengol et al., 2012; Hernandez et al., 2007) .
Dlk1
Sul-pat mice display increased expression of thermogenesis genes in the neonatal period, and decreased lipid accumulation in brown adipose cells (Armengol et al., 2012) . In Gtl2lacZ mat mice, increased Dlk1 expression results in failure of BAT to properly differentiate, and reduced expression of thermogenesis genes (Charalambous et al., 2012) . These data point to Dlk1 as a key regulator of BAT differentiation that controls the capacity for thermogenesis as a mechanism of temperature regulation. Thermogenesis is critical for temperature regulation during the early postnatal period, suggesting that alterations in this process could be involved in the varied developmental phenotypes of both Dlk1 null mice. A BATspecific Dlk1 deletion could be very informative. Second, it is possible that Dlk1 is required in one or more of the tissues examined, but that loss of expression in the specific cell type targeted is masked by paracrine expression from other cell types in the same tissue. Deletion of Dlk1 specifically in myoblasts of developing skeletal muscle (Dlk1 Skm ), for example, showed that Dlk1 expression in whole muscle was decreased to only 65% of control, with the remaining expression derived primarily from endothelial cells within the muscle (Waddell et al., 2010) . Stromal cells in other tissues may similarly compensate for Dlk1 loss in known signaling cells. In the pituitary for example, Dlk1 is expressed in some cells of the intermediate lobe, which might compensate for loss in the anterior somatotrophs. Similarly, Dlk1 expression has been detected in the stroma and acini of e15-16 mouse pancreas, which might compensate for Dlk1 loss in b-cells (da Rocha et al., 2007) .
Third, it is possible that Dlk1 is required in one or more of the cell types analyzed, but that loss of Dlk1 expression is compensated by the related gene Dlk2 (Nueda et al., 2007) . Only recently identified, the function of Dlk2 is not well understood, but its expression pattern shows some overlap with that of Dlk1. Both genes are expressed during embryonic development, although Dlk2 expression is activated primarily during late gestation, while Dlk1 is expressed from at least e11. Dlk2 has been shown to be expressed in the placenta, but expression in the pituitary and pancreas have not been analyzed (Nueda et al., 2007) . While preliminary experiments have suggested that DLK2 functions to oppose DLK1 during adipogenesis, its activities in other cell types are unknown.
Lastly, it is possible that systemic parameters such as survival and growth are under the control of Dlk1 produced by more than one of the tissues analyzed, and that the effects of loss of Dlk1 in any one tissue is compensated in an endocrine manner by Dlk1 production from another tissue. Recapitulating the Dlk1 cons-pat phenotype would then require combinatorial deletion in multiple individual tissue types.
Experimental procedures
Targeting construct design
The ploxPneo-1 plasmid (Nagy et al., 1998) contains two loxP sites flanking a Phosphoglycerate kinase 1 (Pgk1) promoter driven neomycin cassette. A third loxP site was ligated into the SalI restriction site upstream of the Pgk-1 promoter generating the plasmid p3loxNeo. The 28G5 BAC clone (CHORI, Oakland, CA), spanning 3.5 kb upstream of Dlk1 to 69 kb downstream of the Meg3 gene, was used to isolate the mouse Dlk1 gene and its surrounding genomic sequence (Schmidt et al., 2000) . Three DNA fragments, a 3.3 kb NotI/EcoRI fragment, a 4.6 kb EcoRI/BamHI fragment, and a 2.4 kb BamHI/Bam-HI fragment, were excised from 28G5 and ligated into the unique BamHI, NheI, and KpnI sites of p3loxNeo, respectively. The resulting p3loxDDlk1 targeting construct contains three regions of homology to Dlk1 as well as a neomycin cassette.
4.2.
Generation of Dlk1 3lox mice
The targeting construct was linearized using NotI, transfected into E14 embryonic stem cells, and selected using G418. Neomycin resistant clones were screened for homologous recombination using Southern blot analysis, as previously described (Yevtodiyenko et al., 2004) . ES cell DNA was digested with HindIII or BstEII and probed with a 1.3 kb DraI/ XcmI probe corresponding to a region in the 5' flanking region of Dlk1. This assay detected a 9 kb WT or 7 kb targeted band. Targeting of the 3' flank was confirmed using a 1 kb BamHI/ XcmI probe that would bind to a 5 kb WT or 7 kb targeted band. Cells possessing the targeted allele were then microinjected into C57BL/6 (B6) mouse blastocysts to generate chimeric offspring, which were backcrossed to B6 mice to transmit the mutation (Dlk1 
Mice and genotyping
EIIa-Cre mice, which express Cre recombinase under the control of the adenovirus EIIa promoter (B6.FVB-Tg(EIIaCre)C5379Lmgd/J, strain #003724) (Lakso et al., 1996) , were purchased from the Jackson Laboratory (Bar Harbor, Maine, USA) and were bred to the Dlk1 3lox mice to excise the neomycin cassette and generate the Dlk1 floxed (Dlk1 tm1.1Jvs , here denoted as 
Northern analysis
Embryos and placentae were dissected and their genotypes were determined by PCR of yolk sac DNA. Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA), purified by phenol:chloroform:isoamyl alcohol extraction and ethanol precipitation, and Northern blotting was performed, as previously described (Steshina et al., 2006) . Blots were imaged with a Storm Phosphorimager and results were quantified using ImageQuant 5.2 analysis software (GE Healthcare, Piscataway, NJ, USA). The probes for Dlk1 and b-actin were amplified by RT-PCR using the primers:
The Dlk1 probe is specific to a region on exon 6 and the b-actin probe binds to a region spanning exons 3-5. RT-PCR products were run on a 0.8% agarose gel and isolated using QIAquick column purification (Qiagen, Valencia, CA, USA). Probes were radiolabeled by incubation of 50 ng of DNA with 2 u Klenow enzyme, 50 lCi a-32 P, 20 lg BSA, and 10 lL of oligo labeling buffer for 1 h to overnight at room temperature (RT). The radiolabeled probe was purified on a Sephadex G50 spin column (Roche, Indianapolis, IN, USA) and the intensity of radioactivity was determined using a LG6500 Multi-Purpose scintillation counter (Beckman Coulter, Brea, CA, USA).
Measurement of animal and tissue weight
Mice were fed a normal diet after weaning consisting of P5% crude fat (Harlan Teklad LM-485 Mouse/Rat Diet 7912). The mice were weighed at weekly intervals from one to six weeks after birth. In the rIP-Cre, rGh-Cre, Tie1-Cre, and Tie2-Cre crosses, pups carrying one copy of the Dlk1 flox allele and heterozygous for Cre recombinase (+/Dlk1 flox ; Cre/+) were compared to mice heterozygous for Cre recombinase alone (+/+; Cre/+). Data was separated by gender and analyzed for significance using a two-tailed Student's t-test with unequal variance and significance at p < 0.05. Following sacrifice of animals at six weeks, fat pads were dissected and weighed. The reproductive (epididymal or parametrial) and retroperitoneal/inguinal fat pads on one side of the animal were weighed and compared to the body weight of the individual animals. Fat pads as a percentage of total body weight were analyzed for statistical significance using a two-tailed Student's t-test with unequal variance and significance at p < 0.05.
Histological analysis
At six weeks of age, mice were sacrificed and the following tissues were dissected: brain, pituitary, adrenal, tongue (skeletal muscle), thymus, heart, lung, liver, spleen, kidney, pancreas, small intestine, retroperitoneal/inguinal fat pads, reproductive fat pads, and testis (n = 3 of each Dlk1 cons , Dlk1
Ins ,
Dlk1
Gh , and their corresponding littermate controls). Retroperitoneal/inguinal and reproductive fat pads were also analyzed at 16 weeks of age. Tissues were fixed overnight at 4°C in 4% paraformaldehyde in 1· PBS and processed by the University of Illinois at Urbana-Champaign Veterinary Diagnostic Laboratory. Adipocyte cell area was measured using ImageJ software (Abramoff et al., 2004) . Placentae were taken at e12.5, fixed overnight in 4% paraformaldehyde, and sent to Global Path Imaging and Consulting, Ltd. (Metamora, IL, USA) for processing and analysis.
lacZ expression analysis
Pancreases and pituitaries were dissected from Dlk1 Ins and
Dlk1
Gh mice at six weeks of age and fixed in 4% paraformaldehyde in 1· PBS for 1 h on ice. Following fixation, tissues were washed in wash buffer (2 mM MgCl 2 , 0.01% deoxycholic acid, 0.02% NP-40, in PBS) three times for 30 min each at RT. bGalactosidase staining was performed in staining solution (1 mg/ml X-gal in DMF, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl 2 , 0.01% deoxycholic acid, 0.02% NP-40, in PBS) overnight in the dark at RT. The next day, tissues were washed in 1· PBS three times, dehydrated in solutions of increasing ethanol concentration, and infused with paraffin wax using a Shandon Citadel 1000 tissue processor (Fisher Scientific, Pittsburgh, PA, USA). Processed tissues were embedded in blocks of paraffin wax using a Shandon Histocentre 2 embedding machine (Fisher Scientific, Pittsburgh, PA, USA). Finally, embedded tissues were cut into 5-10 lm sections using a Leica RM2125 microtome and counterstained using eosin. Coverslips were applied using Permount (Fisher Scientific, Pittsburgh, PA, USA) and images were taken using a Leica MZFLIII dissecting microscope.
In situ hybridization
Placentae were collected at e12.5 and fixed for 1-2 h in 4% paraformaldehyde in 1· PBS on ice. Fixative was removed by washing the tissues three times with 1· PBS at RT. The placentae were dehydrated, embedded in paraffin wax, and sectioned as described above for lacZ expression. The Tpbpa cRNA probe was made using WT e12.5 embryo cDNA as template with the primers: OL1961-5 0 -TCCAAGGACCTCTGAA GAGCTGAA-3 0 ; OL1962-5 0 -AGGAGGCAGTTAATTTGGGAGAG AG-3 0 . The RT-PCR product was gel isolated and purified using a QIAquick column (Qiagen, Valencia, CA, USA). The purified product was cloned into the pCRII-TOPO vector (Invitrogen, Carlsbad, CA, USA), excised with BstXI, and cloned into the SmaI site in the vector pBSIIKS (Agilent Technologies, Santa Clara, CA, USA). In vitro transcription reactions using either T7 or T3 RNA polymerase were used to create the digoxigenin-labeled cRNA sense or antisense probes, respectively. In situ hybridization was carried out as described previously .
Immunohistochemistry
The following tissues were collected and analyzed using standard immunohistochemical techniques: adult pancre-ases, adult pituitaries, and e12.5 placentae. Tissues were fixed, dehydrated, paraffin embedded and sectioned as described above in Sections 4.7 and 4.8. Heat-induced antigen retrieval (0.3% Sodium Citrate, 0.05% Tween-20, pH 6) was performed followed by washes in 1· PBS. Tissue sections were blocked using 5% donkey normal serum, 1% BSA, 0.5% Tween-20, and 0.75% glycine in 1· PBS for 1 h at RT. Sections were incubated at 4°C overnight with a 1:50 dilution of rabbit anti-mouse DLK1 primary antibody (sc-25437; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After washing, the sections were incubated in a 1:250 dilution of Alexa Fluor 647-conjugated secondary antibody for 2 h at RT (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Sections were rinsed in 1· PBS and DAPI stained (D1306; Life Technologies Corporation, Grand Island, NY, USA). Slides were mounted using Vectashield mounting medium for immunofluorescence (H1000; Vector Laboratories, Burlingame, CA, USA), and imaged on a Zeiss Axiovert 200 M microscope.
Quantitative real-time RT-PCR
Total RNA was extracted from whole adult mouse pituitaries using TRIzol reagent (Invitrogen, Carlsbad, CA, USA), and any DNA contamination was removed by DNase treatment using TURBO DNA-free (Ambion, Austin, TX, USA). Reverse transcription was performed with 1 lg of total RNA using Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Products of reverse transcription were diluted 1:10, and 2 ll of cDNA was used for subsequent PCR analysis. . qRT-PCR was performed in triplicate on each sample using SYBR GreenER (Invitrogen, Carlsbad, CA, USA) under the following conditions: uracil DNA glycosylase (UDG) incubation (50°C for 2 min); UDG inactivation and DNA polymerase activation (95°C for 10 min); followed by 40 cycles of denaturation (94°C for 15 s), annealing (62°C for 30 s), and elongation (72°C for 15 s). A melting curve ranging from 60 to 95°C was run after each reaction was completed to test for primer dimerization or the formation of multiple products. Relative quantification normalized to b-actin was determined using the DDCt method by comparing each sample to the average of all control (rGH-Cre/+) samples, with the control average set to 1.
Fluorescence activated cell sorting
Adult mouse pituitaries (8 each rGH-Cre/+ and Dlk1
Gh-pat ) were dissected and grouped by genotype. Pituitaries were cut into small pieces using surgical blades and incubated in 0.15% trypsin in S-MEM (Spinner's modified Eagle medium) at 37°C with rotating for 3 h. Every 45 min, the pituitary pieces were passed through a glass Pasteur pipette for 3-5 min to further disperse the cells. Fully dispersed cells were pelleted by centrifugation for 5 min at 400g, resuspended in DMEM (Dulbecco's modified Eagle medium), and cell number and viability was scored using a hemacytometer and Trypan blue. Pituitary cells were cultured in DMEM for 1 h at 37°C to allow recovery following dissociation. Cells were resuspended in ice cold 10% FBS in PBS supplemented with 100 nM human GRF (Growth hormone releasing factor, National Hormone and Peptide Program, Torrance, CA, USA) to enhance GH at the cell membrane. Aliquots of rGH-Cre/+ cells were separated for use as ''untreated'' and ''no primary antibody'' controls. A 1:1000 dilution of primary antibody (guinea pig anti-rat GH, National Hormone and Peptide Program, Torrance, CA, USA) was added to cells followed by incubation for 1 h at 4°C in the dark. Cells were washed 3· in ice cold 1· PBS to remove excess primary antibody. Cells were then incubated in 1 lg secondary antibody (goat anti-guinea pig IgG-PE, sc-3732, Santa Cruz Biotechnology, Santa Cruz, CA, USA) in 3% BSA in 1· PBS for 1 h at 4°C in the dark. Following incubation, cells were washed 3· in 1· PBS, resuspended in 3% BSA, 2 mM EDTA in 1· PBS, and immediately taken for fluorescence activated cell sorting (FACS). FACS was performed by the UIC Flow Cytometry Service using a Beckman Coulter MoFlo cell sorter (Brea, CA, USA). DNA was extracted from sorted cells using standard protocols and PCR was performed across the Dlk1 deletion region using primers OL657 and OL655 as described in Section 4.3 above. DNA sequencing was performed by the UIC DNA Services Facility and confirmed loss of Dlk1 exons 5 and 6 from Dlk1
Gh-pat somatotrophs.
Statistical analysis
For determining statistical significance of mouse survival data, a one-tailed Z-test was used. In all other cases, Student's t-test was applied.
